Skip to main content
ARS Pharmaceuticals, Inc. logo

ARS Pharmaceuticals, Inc. — Investor Relations & Filings

Ticker · SPRY ISIN · US82835W1080 US Manufacturing
Filings indexed 491 across all filing types
Latest filing 2025-11-12 Regulatory Filings
Country US United States of America
Listing US SPRY

About ARS Pharmaceuticals, Inc.

https://ars-pharma.com/

ARS Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of innovative, needle-free products for administering therapies. The company's lead product is neffy (epinephrine nasal spray), the first and only FDA-approved needle-free treatment for severe allergic reactions (Type I hypersensitivity), including anaphylaxis. Developed as a patient-friendly alternative to auto-injectors, neffy is designed to be easy to carry and use, addressing challenges such as needle-related risks and hesitation in administration for both patients and caregivers.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2025
Regulatory Filings
2025-11-12 English
Regulatory Filings 2025
Regulatory Filings
2025-11-12 English
10-Q
Interim / Quarterly Report Q3 2025
2025-11-10 English
8-K
Regulatory Filings
2025-11-10 English
Major Shareholding Notification 2025
Major Shareholding Notification
2025-10-02 English
8-K
Regulatory Filings
2025-09-29 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.